Erin Schuler

Erin Schuler, PhD


  • Director, Chemistry, Special Chemistry, and Point of Care, Division of Pathology and Laboratory Medicine
  • Assistant Professor, UC Department of Pathology and Laboratory Medicine

About

Bachelor of Science: Dual Major, Chemistry and Biology, Youngstown State University Youngstown, OH, Aug. 2004–Aug. 2008.

Doctor of Philosophy: Chemistry, Emory University, Laney Graduate School of Arts and Sciences, Atlanta, GA, Aug. 2008–Aug. 2015.

Postdoctoral Research: Emory University Atlanta, GA, July 2015-–Jan. 2018.

Clinical Chemistry Fellow: University of Kentucky, Department of Pathology and Laboratory Medicine, Lexington, KY, Jan. 2018–Jan. 2020.

Publications

Population Pharmacokinetics of Cefepime in Critically Ill Children and Young Adults: Model Development and External Validation for Monte Carlo Simulations and Model-Informed Precision Dosing. Morales Junior, R; Hambrick, HR; Mizuno, T; Pavia, KE; Paice, KM; Tang, P; Schuler, E; Krallman, KA; Johnson, L; Collins, M; Gibson, A; Curry, C; Kaplan, J; Goldstein, S; Tang Girdwood, S. Clinical Pharmacokinetics. 2025; 64:553-564.

Cystatin C Outperforms Creatinine in Predicting Cefepime Clearance in Pediatric Stem Cell Transplant Recipients. Hambrick, HR; Fei, L; Pavia, K; Kaplan, J; Mizuno, T; Tang, P; Schuler, E; Benoit, S; Girdwood, ST. Transplantation and Cellular Therapy. 2024; 30:614.e1-614.e11.

Artesunate acts through cytochrome c to inhibit growth of pediatric AML cells. Hill, KS; Schuler, EE; Ellingson, SR; Kolesar, JM. Scientific Reports. 2023; 13:22383.

In Reply to Toward a Clearer Understanding of Accuracy and Proper Application of the IBP4/SHBG Ratio for Predicting Preterm Delivery. Nerenz, RD; Woodworth, A; Farnsworth, C; Schuler, EE. The journal of applied laboratory medicine. 2022; 7:1006-1008.

FDA Approaches in Monitoring Drug Quality, Forces Impacting the Drug Quality, and Recent Alternative Strategies to Assess Quality in the US Drug Supply. Almeter, PJ; Isaacs, JT; Hunter, AN; Henderson, BS; Platt, T; Mitchell, BJ; Do, D; Brainard, AB; Brown, JE; Stone, RM; Schuler, EE; Naseman, RW; Johnson, GL; Lodder, RA. Journal of Pharmaceutical Innovation. 2022; 17:269-282.

AACC Guidance Document on Laboratory Testing for the Assessment of Preterm Delivery. Farnsworth, C; Schuler, EE; Woodworth, A; Straseski, J; Pschirrer, ER; Nerenz, RD. The journal of applied laboratory medicine. 2021; 6:1032-1044.

KEAP1 Is Required for Artesunate Anticancer Activity in Non-Small-Cell Lung Cancer. Hill, KS; McDowell, A; McCorkle, JR; Schuler, E; Ellingson, SR; Plattner, R; Kolesar, JM. Cancers. 2021; 13:1885.

Potential Process Control Issues with Remdesivir. Almeter, PJ; Isaacs, JT; Schuler, EE; Lodder, RA. 2021; 2021.